Resilient Lifescience
Combating overdose with intelligent drug discovery
Combating overdose with intelligent drug discovery
Resilient Lifescience is a Pittsburgh-based startup founded in 2022, with the mission of combating overdose with intelligent drug discovery. The company's slogan "Combating overdose with intelligent drug discovery" encapsulates its focus on developing a wearable medical device to prevent opioid overdose deaths using naloxone, even when no one else is around. In December 2023, Resilient Lifescience secured a $50.00K Pre Seed Round investment from Innovation Works and AlphaLab Health. This investment reflects the confidence of these esteemed investors in Resilient Lifescience's innovative approach to addressing a critical public health issue. The startup's location in the United States places it at the heart of the global healthcare industry, providing strategic access to key resources and talent. Resilient Lifescience's disruptive technology and commitment to saving lives position it as a compelling investment opportunity in the burgeoning health tech sector.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Pre Seed Round | $50.00K | 2 |
|
06 Dec 2023 |
| Grant | $500.00K | 1 | Richard King Mellon Foundation | 07 Feb 2023 |
| Pre Seed Round | $75.00K | 2 |
|
17 May 2022 |
No recent news or press coverage available for Resilient Lifescience.
We care about your data, and we'd love to use cookies make your experience better.